BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Pharm Country

  Lonza Inc. to Invest $15.1 Million to Expand Antibody Drug Conjugate

  January 9, 2013

   · 

  1 min read
• Business

  Cyberonics Inc. Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies

  January 9, 2013

   · 

  5 min read
• Drug Development

  Theravance, Inc. and Alfa Wasserman Announce Initiation of Phase 2 Study With Velusetrag for Gastroparesis

  January 9, 2013

   · 

  6 min read
• Edwards Lifesciences Corporation CEO Mussallem Details U.S. Sapien Sales Guidance

  January 9, 2013

   · 

  1 min read
• Deals

  Opko Health, Inc. to Acquire Privately Held Cytochroma Inc.

  January 9, 2013

   · 

  5 min read
• Business

  Galapagos NV Delivers Candidate Drug in GlaxoSmithKline Alliance and Receives Milestone Payment

  January 9, 2013

   · 

  2 min read
• Policy

  Ryan & Maniskas, LLP Class Action Lawsuit Against Isis Pharmaceuticals, Inc.

  January 9, 2013

   · 

  3 min read
• Drug Development

  Cell Therapeutics, Inc. Begins Enrollment in Phase 3 PERSIST-1 Trial of Pacritinib for the Treatment of Myelofibrosis

  January 9, 2013

   · 

  6 min read
• Genetown

  Cambridge Heart, Inc. Provides Update

  January 9, 2013

   · 

  3 min read
• Biotech Bay

  Halt Medical, Inc. Introduces Team to Commercialize Acessa™ System for the Treatment of Uterine Fibroids

  January 9, 2013

   · 

  2 min read